Nano-X Imaging Ltd.
NNOXHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeNano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The $73.1M market capitalization puts NNOX squarely in micro-cap range for its industry. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications.
Market Cap
$73.1M
Beta
1.25
P/E (TTM)
—
P/E (Fwd)
-3.10
EPS (TTM)
$-1.15
EPS (Fwd)
$-0.30
ROE
-50.1%
ROA
-22.3%
Cash
$43.9M
Total Debt
$7.6M
Free CF
-$28.9M
52W Change
-79.2%
Annual Financials
Cash vs Debt
Where NNOX stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, NNOX finished 57.30% below its 150-day moving average ($1.78) and 64.81% below its 200-day moving average ($2.16). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is NNOX overbought or oversold?
At the September 3, 2026 close, NNOX's RSI(14) was 19.9, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $43.9M in cash and $7.6M in debt, NNOX maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company is burning cash, with free cash flow at -$28.9M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. ROE of -50.1% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $8.6M (2022) to $13.0M (2025), reflecting a 52% increase over the period.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Nano-X Imaging Ltd.'s trajectory.